Mesoblast says FDA feedback supports filing plans for its cell therapy to treat chronic back pain, showing reduced pain and ...

A downtrend has been apparent in Mesoblast Limited (MESO) lately. While the stock has lost 10.8% over the past week, it could witness a trend reversal as a hammer chart pattern was formed in its last ...

Fintel reports that on January 22, 2026, JEFFERIES upgraded their outlook for Mesoblast Limited - Depositary Receipt ...

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even higher." ...

Mesoblast's remestemcel (Ryoncil) is FDA-approved for steroid-refractory acute graft-versus-host disease in patients two months and older, marking a significant milestone for MSC therapies in the US.

Mesoblast Limited’s MESO shares surged 78.6% on Mar 26, after an encouraging regulatory update from the FDA for its lead product candidate, remestemcel-L, which is being developed for the treatment of ...

We’re no strangers to the concept of superfoods. (C’mon, it’s 2019.) But the now-familiar (and somewhat overhyped) food fad is about to resurface in a new way, and it might actually be better for your ...

Meso Scale Diagnostics, LLC is a biotechnology company that develops, manufactures, and markets instruments and assays for the life sciences industry. The company was founded in 1995 by Christopher P.

Honey-glazed duck with Brussels sprouts, figs soaked in brandy, and potato gratin. Drawing upon the cuisines of France, Italy, Spain, Greece, and North Africa, Meso shows Westchester just how ...